Abbott has taken a step forward in the development of a new addition to its structural heart portfolio, completing the first ...

Medtronic has reported new clinical data from the study of its Evolut transcatheter aortic valve replacement (TAVR) system, ...

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...

Edwards Lifesciences (EW – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Larry ...

LATE-breaking research presented at PCR London Valves 2024 has demonstrated the early safety and effectiveness of the ...

The Myval THV series, known for its innovative contributions to transcatheter aortic valve replacement (TAVR) procedures, ...

8 when his damaged heart valve was found. Instead, he had a heart procedure — a transcatheter aortic valve replacement (TAVR) ...

Medtronic plc MDT recently announced new data for the Evolut Transcatheter Aortic Valve Replacement System (TAVR) at PCR ...

Medtronic (NYSE:MDT) this week shared new clinical data supporting its Evolut Pro/Pro+ transcatheter aortic valve replacement ...

Meril Life Sciences, a leading global med-tech company specializing in cardiovascular and structural heart solutions, marked ...

New York, New York-- (Newsfile Corp. - December 1, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE ...

Meril Life Sciences launched its innovative Myval Octapro Transcatheter Heart Valve at major cardiology events. The product enhances transcatheter aortic valve replacement, offering tailored size ...